[1]冯阳,施京红,蒲柯,等.Nef上调Nrf2/HO-1/NQO1信号通路改善对乙酰氨基酚所致肝损伤作用及机制实验研究[J].陕西医学杂志,2025,54(9):1161-1169,1207.[doi:DOI:10.3969/j.issn.1000-7377.2025.09.002]
 FENG Yang,SHI Jinghong,PU Ke,et al.Improvement effect and mechanism of Nef up-regulating Nrf2/HO-1/NQO1 signaling pathway on acetaminophen-induced liver injury[J].,2025,54(9):1161-1169,1207.[doi:DOI:10.3969/j.issn.1000-7377.2025.09.002]
点击复制

Nef上调Nrf2/HO-1/NQO1信号通路改善对乙酰氨基酚所致肝损伤作用及机制实验研究

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年9期
页码:
1161-1169,1207
栏目:
基础研究
出版日期:
2025-09-05

文章信息/Info

Title:
Improvement effect and mechanism of Nef up-regulating Nrf2/HO-1/NQO1 signaling pathway on acetaminophen-induced liver injury
作者:
冯阳1施京红2蒲柯3罗婷3丁辉4
(1.西北大学附属医院 西安市第三医院,陕西 西安 710018;2.陕西中医药大学,陕西 咸阳 712046;3.川北医学院附属医院,四川 南充 637000;4.陕西省中医药研究院,陕西 西安 710003)
Author(s):
FENG Yang1SHI Jinghong2PU Ke3LUO Ting3DING Hui4
(1.The Affiliated Hospital of Northwest University,Xi’an 710018,China;2.Shaanxi University of Chinese Medicine,Xianyang 712046,China;3.The Affiliated Hospital of North Sichuan Medical College,Nanchong 637000,China;4.Shaanxi Academy of Traditional Chinese Medicine,Xi’an 710003,China)
关键词:
肝损伤甲基莲心碱对乙酰氨基酚氧化应激炎症反应信号通路小鼠
Keywords:
Liver injuryNeferineAcetaminophenOxidative stressInflammatory responseSignaling pathwayMice
分类号:
R 285
DOI:
DOI:10.3969/j.issn.1000-7377.2025.09.002
文献标志码:
A
摘要:
目的:探讨甲基莲心碱(Nef)对对乙酰氨基酚(APAP)所致肝损伤的改善作用及可能机制。方法:将50只小鼠随机分为0.9%氯化钠溶液(NS)对照组、APAP+NS组、APAP+Nef(5)组、APAP+Nef(10)组和APAP+Nef(20)组,每组10只。APAP+Nef(5)组、APAP+Nef(10)组和APAP+Nef(20)组均给予400 mg/kg APAP建立药物性肝损伤(DILI)模型,Nef剂量为5、10、20 mg/kg,其余两组以等量0.9%氯化钠溶液替代Nef进行灌胃处理。分析Nef对APAP诱导的肝功能和形态学损伤、氧化应激反应、炎症反应、细胞凋亡及Nrf2相关抗氧化信号通路的影响。结果:与NS对照组比较,APAP+NS组丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、IL-10、3-硝基酪氨酸(3-NT)和诱导型一氧化氮合酶(iNOS)水平以及B细胞淋巴瘤因子-2(Bcl-2)相关蛋白X(Bax)和裂解型半胱氨酸蛋白酶-3(Cleaved caspase-3)蛋白表达升高,超氧化物歧化酶(SOD)、谷胱甘肽(GSH)、谷胱甘肽过氧化物酶(GSH-Px)水平降低,Bcl-2蛋白表达降低,核因子-红细胞2相关因子2(Nrf2)、血红素加氧酶1(HO-1)、NAD(P)H醌脱氢酶1(NQO1)mRNA和蛋白表达降低,肝组织病理损伤加重(均P<0.05)。与APAP+NS组比较,APAP+Nef(10)组和APAP+Nef(20)组上述指标改善,肝组织病理损伤减轻,且APAP+Nef(20)组优于APAP+Nef(10)组(均P<0.05)。结论:Nef能够改善APAP诱导的肝损伤,其机制可能为通过上调Nrf2/HO-1/NQO1信号通路抑制氧化应激反应。
Abstract:
Objective:To explore the improvement effect and possible mechanism of Nef on liver injury induced by acetaminophen (APAP).Methods:A total of 50 mice were randomly divided into NS control group,APAP+NS group,APAP+Nef(5) group,APAP+Nef(10) group and APAP+Nef(20) group,with 10 mice in each group.The APAP+Nef(5) group,APAP+Nef(10) group and APAP+Nef(20) group were all given 400 mg/kg APAP to establish drug-induced liver injury (DILI) models,with Nef doses of 5,10 and 20 mg/kg.The other two groups were treated with an equal amount of 0.9% sodium chloride solution instead of Nef by gavage.The effects of Nef on APAP induced liver function and morphological damage,oxidative stress response,inflammatory response,cell apoptosis and Nrf2 related antioxidant signaling pathways were analyzed.Results:Compared with the NS control group,the APAP+NS group showed increased levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST),tumor necrosis factor - α (TNF - α),interleukin-6 (IL-6),IL-10,3-nitrotyrosine (3-NT) and inducible nitric oxide synthase (iNOS),as well as increased protein expression of B cell lymphoma factor-2 (Bcl-2)-related protein X (Bax) and Cleaved caspase-3,decreased levels of superoxide dismutase (SOD),glutathione (GSH) and glutathione peroxidase (GSH-Px),decreased protein expression of Bcl-2,and the mRNA and protein expressions of nuclear factor erythroid 2 related factor 2 (Nrf2),hemeoxygenase-1 (HO-1) and NAD(P)H quinone dehydrogenase 1 (NQO1) decreased,and the pathological damage to liver tissue worsened (all P<0.05).Compared with the APAP+NS group,the APAP+Nef(10) group and APAP+Nef(20) group showed a improvement in the above indicators and a reduction in liver tissue pathological damage,and the APAP+Nef(20) group was superior to the APAP+Nef(10) group (all P<0.05).Conclusion:Nef can improve APAP induced liver injury,possibly by up-regulating the Nrf2/HO-1/NQO1 signaling pathway to inhibit oxidative stress response.

参考文献/References:

[1]BJRNSSON E S,BERGMANN O M,BJRNSSON H K,et al.Incidence,presentation,and outcomes in patients with drug-induced liver injury in the general population of Iceland[J].Gastroenterology,2013,144(7):1419-1425.
[2]LI X,TANG J,MAO Y.Incidence and risk factors of drug-induced liver injury[J].Liver Int,2022,42(9):1999-2014.
[3]BJRNSSON H K,BJRNSSON E S.Drug-induced liver injury:Pathogenesis,epidemiology,clinical features,and practical management[J].Eur J Intern Med,2022,97:26-31.
[4]LARSON A M,POLSON J,FONTANA R J,et al.Acetaminophen-induced acute liver failure:results of a United States multicenter,prospective study[J].Hepatology,2005,42(6):1364-1372.
[5]WIN S,THAN T A,KAPLOWITZ N.C-Jun-N terminal kinase-mediated degradation of γ-glutamylcysteine ligase catalytic subunit inhibits GSH recovery after acetaminophen treatment:Role in sustaining JNK activation and liver injury[J].Antioxid Redox Signal,2023,38(16-18):1071-1081.
[6]CIRCU M L,AW T Y.Reactive oxygen species,cellular redox systems,and apoptosis[J].Free Radic Biol Med,2010,48(6):749-762.
[7]曾胜澜,梁健芬,邢俊娥,等.铁死亡在药物性肝损伤中的作用机制及治疗研究进展[J].陕西医学杂志,2024,53(12):1718-1720,1725.
[8]JAESCHKE H,RAMACHANDRAN A.Acetaminophen hepatotoxicity:Paradigm for understanding mechanisms of drug-induced liver injury[J].Annu Rev Pathol,2024,19:453-478.
[9]HAN D,SHINOHARA M,YBANEZ M D,et al.Signal transduction pathways involved in drug-induced liver injury[J].Handb Exp Pharmacol,2010,(196):267-310.
[10]李悦宁,肖柯心,赵冰洁,等.桑玉膏对对乙酰氨基酚诱导的小鼠急性肝损伤保护作用研究[J].陕西中医,2023,44:154-158.
[11]JUNG H A,JIN S E,CHOI R J,et al.Anti-amnesic activity of neferine with antioxidant and anti-inflammatory capacities,as well as inhibition of ChEs and BACE1[J].Life Sci,2010,87(13-14):420-430.
[12]ZHAO L,WANG X,CHANG Q,et al.Neferine,a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis[J].Eur J Pharmacol,2010,627(1-3):304-312.
[13]LIU X,SONG X,LU J,et al.Correction:Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice[J].Oncotarget,2022,13:810-811.
[14]POORNIMA P,WENG C F,PADMA V V.Neferine,an alkaloid from lotus seed embryo,inhibits human lung cancer cell growth by MAPK activation and cell cycle arrest[J].Biofactors,2014,40(1):121-131.
[15]SUGIMOTO Y,FURUTANI S,ITOH A,et al.Effects of extracts and neferine from the embryo of Nelumbo nucifera seeds on the central nervous system[J].Phytomedicine,2008,15(12):1117-1124.
[16]SUGIMOTO Y,FURUTANI S,NISHIMURA K,et al.Antidepressant-like effects of neferine in the forced swimming test involve the serotonin1A (5-HT1A) receptor in mice[J].Eur J Pharmacol,2010,634(1-3):62-67.
[17]ZHOU Y J,XIANG J Z,YUAN H,et al.Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates[J].Thromb Res,2013,132(2):202-210.
[18]BASKARAN R,KALAISELVI P,HUANG C Y,et al.Neferine,a bisbenzylisoquinoline alkaloid,offers protection against cobalt chloride-mediated hypoxia-induced oxidative stress in muscle cells[J].Integr Med Res,2015,4(4):231-241.
[19]DING H,SHI J H,WANG Y,et al.Neferine inhibits cultured hepatic stellate cell activation and facilitates apoptosis:A possible molecular mechanism[J].Eur J Pharmacol,2011,650(1):163-169.
[20]施京红,闫文慧,朱雅男,等.甲基莲心碱对肝纤维化大鼠肝脏的保护作用[J].中药材,2014,37(10):1845-1848.
[21]施京红,丁辉,董蕾.甲基莲心碱对大鼠肝星状细胞增殖的影响[J].陕西中医,2014,35(4):502-505,510.
[22]RUMACK B H.Acetaminophen misconceptions[J].Hepatology,2004,40(1):10-15.
[23]SUN Y K,ZHANG Y F,XIE L,et al.Progress in the treatment of drug-induced liver injury with natural products[J].Pharmacol Res,2022,183:106361.
[24]BEGER R D,BHATTACHARYYA S,YANG X,et al.Translational biomarkers of acetaminophen-induced acute liver injury[J].Arch Toxicol,2015,89(9):1497-1522.
[25]BAJT M L,KNIGHT T R,FARHOOD A,et al.Scavenging peroxynitrite with glutathione promotes regeneration and enhances survival during acetaminophen-induced liver injury in mice[J].J Pharmacol Exp Ther,2003,307(1):67-73.
[26]DAVID JOSEPHY P.The molecular toxicology of acetaminophen[J].Drug Metab Rev,2005,37(4):581-594.
[27]BAJT M L,KNIGHT T R,LEMASTERS J J,et al.Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes:protection by N-acetyl cysteine[J].Toxicol Sci,2004,80(2):343-349.
[28]YAN M,HUO Y,YIN S,et al.Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions[J].Redox Biol,2018,17:274-283.
[29]DU K,RAMACHANDRAN A,JAESCHKE H.Oxidative stress during acetaminophen hepatotoxicity:Sources,pathophysiological role and therapeutic potential[J].Redox Biol,2016,10:148-156.
[30]CAI X,CAI H,WANG J,et al.Molecular pathogenesis of acetaminophen-induced liver injury and its treatment options[J].J Zhejiang Univ Sci B,2022,23(4):265-285.
[31]KAIBORI M,OKUMURA T,SATO K,et al.Inducible Nitric oxide synthase expression in liver injury:Liver protective effects on primary rat hepatocytes[J].Inflamm Allergy Drug Targets,2015,14(2):77-83.
[32]KNIGHT T R,KURTZ A,BAJT M L,et al.Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity:Role of mitochondrial oxidant stress[J].Toxicol Sci,2001,62(2):212-220.
[33]WANG F,YUAN Q,CHEN F,et al.Fundamental mechanisms of the cell death caused by nitrosative stress[J].Front Cell Dev Biol,2021,9:742483.
[34]LAWSON J A,FISHER M A,SIMMONS C A,et al.Inhibition of Fas receptor (CD95)-induced hepatic caspase activation and apoptosis by acetaminophen in mice[J].Toxicol Appl Pharmacol,1999,156(3):179-186.
[35]LIU Z X,HAN D,GUNAWAN B,et al.Neutrophil depletion protects against murine acetaminophen hepatotoxicity[J].Hepatology,2006,43(6):1220-1230.
[36]LATCHOUMYCANDANE C,GOH C W,ONG M M,et al.Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury[J].Hepatology,2007,45(2):412-421.
[37]MACANAS-PIRARD P,YAACOB N S,LEE P C,et al.Glycogen synthase kinase-3 mediates acetaminophen-induced apoptosis in human hepatoma cells[J].J Pharmacol Exp Ther,2005,313(2):780-789.
[38]ITOH K,WAKABAYASHI N,KATOH Y,et al.Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles[J].Genes Cells,2003,8(4):379-391.
[39]GOLDRING C E,KITTERINGHAM N R,ELSBY R,et al.Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice[J].Hepatology,2004,39(5):1267-1276.
[40]GUM S I,CHO M K.Recent updates on acetaminophen hepatotoxicity:The role of Nrf2 in hepatoprotection[J].Toxicol Res,2013,29(3):165-172.
[41]LALITHA G,POORNIMA P,ARCHANAH A,et al.Protective effect of neferine against isoproterenol-induced cardiac toxicity[J].Cardiovasc Toxicol,2013,13(2):168-179.
[42]WANG J,KAN Q,LI J,et al.Effect of neferine on liver ischemia-reperfusion injury in rats[J].Transplant Proc,2011,43(7):2536-2539.
[43]YU Y,SUN S,WANG S,et al.Liensinine- and neferine-induced cardiotoxicity in primary neonatal rat cardiomyocytes and human-induced pluripotent stem cell-derived cardiomyocytes[J].Int J Mol Sci,2016,17(2):186.
[44]HUANG Y,BAI Y,ZHAO L,et al.Pharmacokinetics and metabolism of neferine in rats after a single oral administration[J].Biopharm Drug Dispos,2007,28(7):361-372.

相似文献/References:

[1]迟 旭,漆 沄△,陈 娟,等.初次抗结核治疗诱发药物性肝损伤临床特点及发病危险因素的Logistic回归分析[J].陕西医学杂志,2019,(1):67.

备注/Memo

备注/Memo:
国家自然科学基金资助项目(82204877)
更新日期/Last Update: 2025-09-04